Boston Scientific, a U.S.-based medical device manufacturer, has disclosed a cyberattack that is causing a “global disruption” to its operations, as reported in a federal regulatory filing with the U.S. Securities and Exchange Commission. The company, known for producing implanted devices such as pacemakers and defibrillators, experienced “disruptions and limitations of access” to critical IT systems and business applications starting on Tuesday. The attack has impacted the company’s ability to ship and process orders, though Boston Scientific has not specified whether the disruption extends to patients with medical devices and implants.

In response to inquiries, Boston Scientific spokesperson Chanel Hastings provided the company’s public statement but declined to comment on potential patient impact, recommended actions for patients, or details about the incident itself. The company’s investigation is ongoing, and a timeline for system restoration remains unknown. The cyberattack at Boston Scientific follows a series of recent breaches affecting other health technology companies, including Abbott Laboratories, Medtronic, and Stryker. Public records indicate that Boston Scientific relies heavily on Microsoft and Amazon Web Services for its corporate infrastructure. Source

This is a summary. Read the original at techcrunch.com.